These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 232024
1. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension. Case DB, Atlas SA, Laragh JH. Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024 [Abstract] [Full Text] [Related]
2. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor. Case DB, Laragh JH. Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461 [Abstract] [Full Text] [Related]
3. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF, Russell GI, Swales JD, Thurston H. J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [Abstract] [Full Text] [Related]
4. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril. Zawada ET, Stinson J, Ramirez G. Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479 [Abstract] [Full Text] [Related]
5. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat. Thurston H, Bing RF, Marks ES, Swales JD. Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225 [Abstract] [Full Text] [Related]
7. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225). Imai Y, Abe K, Otsuka Y, Sakurai Y, Yoshinaga K. Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048 [Abstract] [Full Text] [Related]
8. Detection of renovascular hypertension with angiotensin II blockade. Baer L, Parra-Carrilo JZ, Radichevich I, Williams GS. Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983 [Abstract] [Full Text] [Related]
11. Maximal discrimination of renovascular from essential hypertension by the saralasin test. Maxwell MH, Varady P, Zawada ET, Burkhalter JF, Waks U, Marks L. Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071 [No Abstract] [Full Text] [Related]
12. Angiotensin blockade in renovascular hypertension: a controlled, prospective study. Marks LS, Maxwell MH, Gross C, Waks U, Kaufman JJ. Br J Urol; 1977 Jun; 49(3):181-8. PubMed ID: 334316 [Abstract] [Full Text] [Related]
13. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor. Fagard RH, Amery AK, Lijnen PJ, Reybrouck TM. Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956 [Abstract] [Full Text] [Related]
15. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)]. Mimran A, Deschodt G, Barjon P, Mary H, Thevenet A. Nouv Presse Med; 1978 Dec 02; 7(43):3889-93. PubMed ID: 733540 [Abstract] [Full Text] [Related]